Altered Bile Acid Signaling Correlates With Antipsychotic-Induced Weight Gain in Children
Kinetics measurements The HT adducts were prepared as described previously
When CREB is phosphorylated by JNK, its ability to activate the BDNF promoter is diminished, resulting in decreased BDNF production (Motaghinejad et al
GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)along with tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, have transformed the management of type 2 diabetes and obesity
Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline
Luo EF, Li HX, Qin YH, Qiao Y, Yan GL, Yao YY